KYOTO – Researchers have succeeded in improving the treatment of Parkinson’s disease by using human embryonic stem cells to create nerve cells that produce dopamine and then transplanting the cells into monkeys’ brains.
Four monkeys with Parkinson’s disease — and previously unable to walk due to their symptoms — improved substantially after the human nerve cells were transplanted into their brains, reducing the shaking in their limbs and leading to some regaining the ability to walk, the research team, including Kyoto University professor Jun Takahashi, said Tuesday.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.